← Leaderboards
Michael Allon
University Of Alabama At Birmingham
$9,213,764
Attributed
$12,004,051
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,004,051 · 7
By mechanism
R01$9,328,044 · 3
U01$1,742,684 · 2
K24$501,187 · 1
R21$432,136 · 1
Top collaborators
- Mariana Murea5 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Zdenek Hel$11,247,627
- Gabriel A Elgavish$1,081,734
- Janusz H Kabarowski$1,990,528
- Ivan D Maya$331,319
- Sadeep Shrestha$2,747,741
Others in their field
Top investigators on “Hemodialysis”
- Gerald J Beck · Cleveland Clinic Foundation$25,607,449
- Laura M Dember · Univ Of North Carolina Chapel Hill$15,973,453
- Sanjay Misra · Mayo Clinic Rochester$12,663,075
- Myles S Wolf · Duke University$11,798,574
- Stuart Johnston Knechtle · University Of Wisconsin Madison$11,789,092
- Alfred K. Cheung · University Of Utah$11,215,629
Research focus
HemodialysisFistulaBlood VesselsDialysis ProcedureOperative Surgical ProceduresEnd Stage Renal FailureInfectionFollow-UpCathetersDependenceCessation Of LifeArteriovenous FistulaProceduresChronicEnsureClinical TrialsVenousPatient PreferencesCaringReportingDialysis PatientsGrantHuman SubjectMedical Complication
Grant awards (29)
A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS Trial$828,855
R01 · FY2025 · AG
A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS Trial$1,016,814
R01 · FY2024 · AG
A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS Trial$1,191,406
R01 · FY2023 · AG
Barriers to arteriovenous fistula use in black hemodialysis patients$457,621
R01 · FY2023 · MD · contact PI
A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS Trial$1,253,177
R01 · FY2022 · AG
Barriers to arteriovenous fistula use in black hemodialysis patients$455,793
R01 · FY2022 · MD · contact PI
A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS Trial$1,290,322
R01 · FY2021 · AG
Barriers to arteriovenous fistula use in black hemodialysis patients$453,628
R01 · FY2021 · MD · contact PI
Barriers to arteriovenous fistula use in black hemodialysis patients$451,621
R01 · FY2020 · MD · contact PI
Barriers to arteriovenous fistula use in black hemodialysis patients$462,828
R01 · FY2019 · MD · contact PI
Choice of vascular access and patient outcomes among older hemodialysis patients$197,693
R21 · FY2016 · DK · contact PI
Choice of vascular access and patient outcomes among older hemodialysis patients$234,443
R21 · FY2015 · DK · contact PI
Vascular abnormalities in patients receiving a dialysis access.$334,005
R01 · FY2013 · DK · contact PI
Vascular abnormalities in patients receiving a dialysis access.$349,511
R01 · FY2012 · DK · contact PI
Vascular abnormalities in patients receiving a dialysis access.$352,940
R01 · FY2011 · DK · contact PI
Vascular abnormalities in patients receiving a dialysis access.$429,523
R01 · FY2010 · DK · contact PI
Hemodialysis Vascular Access Clinical Trials Consortium$65,000
U01 · FY2007 · DK · contact PI
Hemodialysis Vascular Access Clinical Trials Consortium$130,766
U01 · FY2006 · DK · contact PI
HEMODIALYSIS VASCULAR ACCESS CLINICAL TRIALS CONSORTIUM$289,830
U01 · FY2005 · DK
Vascular Access in Hemodialysis Patients$104,630
K24 · FY2005 · DK
HEMODIALYSIS VASCULAR ACCESS CLINICAL TRIALS CONSORTIUM$294,375
U01 · FY2004 · DK
Vascular Access in Hemodialysis Patients$102,369
K24 · FY2004 · DK
HEMODIALYSIS VASCULAR ACCESS CLINICAL TRIALS CONSORTIUM$283,254
U01 · FY2003 · DK
Vascular Access in Hemodialysis Patients$100,173
K24 · FY2003 · DK
HEMODIALYSIS VASCULAR ACCESS CLINICAL TRIALS CONSORTIUM$299,155
U01 · FY2002 · DK
Vascular Access in Hemodialysis Patients$98,042
K24 · FY2002 · DK
MORTALITY AND MORBIDITY IN HEMODIALYSIS PATIENTS$152,578
U01 · FY2001 · DK
Vascular Access in Hemodialysis Patients$95,973
K24 · FY2001 · DK
MORTALITY AND MORBIDITY IN HEMODIALYSIS PATIENTS$227,726
U01 · FY2000 · DK